These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26542381)

  • 1. Incorporating Long-acting Reversible Contraception Into Primary Care: A Training and Practice Innovation.
    Pace LE; Dolan BM; Tishler LW; Gooding HC; Bartz D
    Womens Health Issues; 2016; 26(2):131-4. PubMed ID: 26542381
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Acting Reversible Contraceptives and Adolescents: Assessing Benefits and Overcoming Barriers.
    McKnight ER; Berlan ED
    Adolesc Med State Art Rev; 2014 Aug; 25(2):347-59. PubMed ID: 27132318
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-acting reversible contraception: reducing unintended pregnancies.
    Ruddick C
    Community Pract; 2009 Sep; 82(9):24-7. PubMed ID: 19788120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing and Conducting a Regional, Hands-on Long-Acting Reversible Contraception Training Center in Primary Care.
    Rubin SE; Maldonado L; Fox K; Rosenberg R; Wall J; Prine L
    Womens Health Issues; 2018; 28(5):375-378. PubMed ID: 29891213
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher uptake of long-acting reversible and permanent methods of contraception by Australian women living in rural and remote areas.
    Lucke JC; Herbert DL
    Aust N Z J Public Health; 2014 Apr; 38(2):112-6. PubMed ID: 24690048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes towards long-acting reversible methods of contraception in general practice in the UK.
    Wellings K; Zhihong Z; Krentel A; Barrett G; Glasier A
    Contraception; 2007 Sep; 76(3):208-14. PubMed ID: 17707718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting reversible methods of contraception: unified training.
    Britton A; Connolly A
    J Fam Plann Reprod Health Care; 2014 Apr; 40(2):80-1. PubMed ID: 24648528
    [No Abstract]   [Full Text] [Related]  

  • 10. Applying principles from behavioral economics to promote long-acting reversible contraceptive (LARC) methods.
    Stevens J; Berlan ED
    Perspect Sex Reprod Health; 2014 Sep; 46(3):165-70. PubMed ID: 24588986
    [No Abstract]   [Full Text] [Related]  

  • 11. Nexplanon® removals in a community sexual and reproductive health service.
    Chaudhry F
    J Fam Plann Reprod Health Care; 2016 Apr; 42(2):160-1. PubMed ID: 26747656
    [No Abstract]   [Full Text] [Related]  

  • 12. Examining quality of contraceptive services for adolescents in Oregon's family planning program.
    Rodriguez MI; Darney BG; Elman E; Linz R; Caughey AB; McConnell KJ
    Contraception; 2015 Apr; 91(4):328-35. PubMed ID: 25545334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-acting reversible contraception use among unmarried young adults.
    Dempsey AR; Billingsley CC; Savage AH; Korte JE
    Am J Obstet Gynecol; 2012 Jun; 206(6):526.e1-5. PubMed ID: 22425402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.
    Blumenthal PD; Voedisch A; Gemzell-Danielsson K
    Hum Reprod Update; 2011; 17(1):121-37. PubMed ID: 20634208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive procedures.
    Beasley A; Schutt-Ainé A
    Obstet Gynecol Clin North Am; 2013 Dec; 40(4):697-729. PubMed ID: 24286997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services.
    Turok DK; Gawron LM; Lawson S
    Fertil Steril; 2016 Nov; 106(6):1273-1281. PubMed ID: 27717553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group
    Obstet Gynecol; 2017 Nov; 130(5):e251-e269. PubMed ID: 29064972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for female contraception: a model for innovation in drug delivery systems.
    Merkatz RB; Tokay B; Sitruk-Ware RL
    Clin Pharmacol Ther; 2009 May; 85(5):553-7. PubMed ID: 19295503
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal and intrauterine contraception for women aged 40 years and older.
    Cwiak C; Allen R; Kaunitz AM
    Womens Health (Lond); 2013 Sep; 9(5):421-4. PubMed ID: 24007246
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.